Insulin Glargine (Lantus) and Cancer
One of our Docturnal bloggers has reported that Lantus worked for them in maintaining baseline sugar levels but was cynical about its long term side effects associated with Cancer as reported in the year 2007-2008. The blog can be found over here and here is some interesting information in response to the news on the side effects.
Patients with type1 or type2 diabetes have often reported that there has been tremendous improvement in their sugar levels since they started using the same. One them even casually mentioned that they are now completely dependent on the Lantus and were wondering what would happen if there was a III world war and a shortage of the medication.
American Diabetes Association (ADA) concluded that the studies on four different populations were conflicting and confusing and advises patients using insulin not to stop taking the same. While FDA has not concluded that there is a causal relationship between Lantus and Cancer NOR is advising to discontinue prescribing the product by health care professionals, FDA encourages prescribers and consumers to report side effects of the usage to FDA’s MedWatch here.
On a more promising and positive note, CHMP (Committee for Medicinal Products for Human Use) and EMEA (European Medicines Agency) have concluded safety and inconsistent Cancer association respectively. More information and articles are available here
About Lantus (Insulin Glargine): An Analogue injection which is similar to human insulin with modified properties which control the duration in the body which in this case is 24 Hours